Clinical Trials Browser

Breast Neoplasms, Male × Vaccines × Breast × Clear all

NCT03630809 2022-04-25

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Phase 2 Terminated

Breast Neoplasms, Breast Neoplasms, Male

NCT01042535 2018-04-11

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

44 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male